Company profile

Hyundai Pharm

004310 · KRX

Public Market Listing

004310KRX

KRX primary exchange listing

Live quotes, historical charts, and market capitalization for Hyundai Pharm are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
2Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Candesartan/Amlodipine
Phase 3
Angiotensin II type 1 receptor / L-type calcium channel (dual)Small molecule
Atherosclerotic Cardiovascular Disease
Candesartan/Rosuvastatin/Ezetimibe
Phase 3
AT1 receptor; NPC1L1; HMG-CoA reductaseSmall molecule
Atherosclerotic Cardiovascular Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.